173 related articles for article (PubMed ID: 9028355)
21. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
22. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
[TBL] [Abstract][Full Text] [Related]
23. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Camps C; Sirera R; Bremnes R; Blasco A; Sancho E; Bayo P; Safont MJ; Sánchez JJ; Tarón M; Rosell R
Lung Cancer; 2005 Dec; 50(3):339-46. PubMed ID: 16139926
[TBL] [Abstract][Full Text] [Related]
24. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD
Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061
[TBL] [Abstract][Full Text] [Related]
25. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
[TBL] [Abstract][Full Text] [Related]
26. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
29. [Mutations of ras and p53 genes in human non-small cell lung cancer cell lines and their clinical significance].
Mitsudomi T; Oyama T; Gazdar AF; Minna JD; Okabayashi K; Shirakusa T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):944-7. PubMed ID: 1361656
[TBL] [Abstract][Full Text] [Related]
30. K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.
Pelosi G; Scarpa A; Manzotti M; Veronesi G; Spaggiari L; Fraggetta F; Nappi O; Benini E; Pasini F; Antonello D; Iannucci A; Maisonneuve P; Viale G
Mod Pathol; 2004 May; 17(5):538-46. PubMed ID: 14990969
[TBL] [Abstract][Full Text] [Related]
31. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
32. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
[TBL] [Abstract][Full Text] [Related]
33. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
34. Analysis of K-ras gene mutations in lung carcinomas: correlation with gender, histological subtypes, and clinical outcome.
Wang YC; Lee HS; Chen SK; Yang SC; Chen CY
J Cancer Res Clin Oncol; 1998; 124(9):517-22. PubMed ID: 9808427
[TBL] [Abstract][Full Text] [Related]
35. K-ras codon 12 mutations detected with enriched PCR method in operable non-small cell lung cancer.
Kovalchuk O; Chyczewska E; Niklinska W; Niklinski J; Naumnik W; Chyczewski L
Folia Histochem Cytobiol; 2001; 39 Suppl 2():68-9. PubMed ID: 11820632
[TBL] [Abstract][Full Text] [Related]
36. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M
Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482
[TBL] [Abstract][Full Text] [Related]
37. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
38. Detection of k-ras point mutations in codons 12 and 13 in non-small cell lung cancers.
Hsu NY; Chen CY; Wu CH; Liu TJ; Kwan PC; Hsu CP; Hsia JY; Chang WT
J Formos Med Assoc; 1996 Oct; 95(10):741-5. PubMed ID: 8961670
[TBL] [Abstract][Full Text] [Related]
39. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
Nemunaitis J; Klemow S; Tong A; Courtney A; Johnston W; Mack M; Taylor W; Solano M; Stone M; Mallams J; Mues G
Am J Clin Oncol; 1998 Apr; 21(2):155-60. PubMed ID: 9537203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]